Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 164 Records) |
Query Trace: Disease Progression and TP53[original query] |
---|
Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies. The journal of gene medicine 2023 9 e3600. Hua Li, Yichen Wang, Guangxiao Li, Jian Xiong, Lingshan Qin, Qirong Wen, Chaomin Y |
Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023 9 . Wenbin Shen, Chuyu Jing, Wenjuan Tian, Wei Zhang, Yulan Ren, Boer Shan, Huaying Wa |
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma. Annals of hematology 2023 9 . Osama Abd El Hameed Ebid, Lobna R Ezz El Arab, Amr S Saad, Mai Ezz El Din, Nermeen Mostafa, Menha Swell |
Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression. Cancers 2023 8 15 (15): . Sungun Bang, Dongju Won, Saeam Shin, Kang Su Cho, Jae Won Park, Jongsoo Lee, Young Deuk Choi, Suwan Kang, Seung-Tae Lee, Jong Rak Choi, Hyunho H |
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study. The Lancet. Haematology 2023 12 11 (1): e51-e61. Catherine Cargo, Elsa Bernard, Tumas Beinortas, Kelly L Bolton, Paul Glover, Helen Warren, Daniel Payne, Rukhsaar Ali, Alesia Khan, Mike Short, Suzan Van Hoppe, Alex Smith, Jan Taylor, Paul Evans, Elli Papaemmanuil, Simon Crou |
Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. Signal transduction and targeted therapy 2023 11 8 (1): 429. Yiqun Han, Jiayu Wang, Tao Sun, Quchang Ouyang, Jianwen Li, Jie Yuan, Binghe |
Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 10 . Paul Stockhammer, Michael Grant, Anna Wurtz, Giorgia Foggetti, F Expósito, Jianlei Gu, Hongyu Zhao, Jungmin Choi, Sangyun Chung, Fangyong Li, Zenta Walther, Julia Dietz, Emily Duffield, Scott Gettinger, Katerina Politi, Sarah B Goldbe |
DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients. Cancers 2023 10 15 (20): . Dorota Butkiewicz, Ma?gorzata Krze?niak, Agnieszka Gdowicz-K?osok, Krzysztof Sk?adowski, Tomasz Rutkows |
Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with Radiotherapy. Current oncology (Toronto, Ont.) 2024 8 31 (8): 4397-4405. Atsushi Motegi, Shun-Ichiro Kageyama, Yukie Kashima, Hidenari Hirata, Hidehiro Hojo, Masaki Nakamura, Takeshi Fujisawa, Tomohiro Enokida, Makoto Tahara, Kazuto Matsuura, Sadamoto Zen |
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer. International journal of cancer 2024 8 . Charlotte K Kindt, Carla L Alves, Sidse Ehmsen, Amalie Kragh, Thomas Reinert, Marianne Vogsen, Annette R Kodahl, Jeanette D Rønlev, Dilan Ardik, Anna L Sørensen, Kirstine Evald, Mia L Clemmensen, Johan Staaf, Henrik J Ditz |
Clonal evolution process from essential thrombocythemia to acute myeloid leukemia in the original patient from whom the CALR-mutated Marimo cell line was established. Nagoya journal of medical science 2024 7 86 (2): 326-332. Yoko Ushijima, Yuichi Ishikawa, Takahiro Nishiyama, Naomi Kawashima, Takashi Kanamori, Masashi Sanada, Hitoshi Kiy |
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. Journal of thoracic disease 2024 7 16 (6): 3782-3793. Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, Saiama N Waq |
Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-institution Cohort of 2,390 patients. World neurosurgery 2024 6 . Danny John, Mohammed Alshalalfa, Timoteo Almeida, Anna Murray, Joao Marques, Gregory Azzam, Eric A Mellon, Carolina G Benjamin, Ricardo J Komotar, Michael Ivan, Brandon Mahal, Benjamin J Ri |
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients. Cancer drug resistance (Alhambra, Calif.) 2024 6 7 21. Gabriele Perrone, Luigi Rigacci, Giandomenico Roviello, Ida Landini, Alberto Fabbri, Lorenzo Iovino, Benedetta Puccini, Emanuele Cencini, Enrico Orciuolo, Monica Bocchia, Alberto Bosi, Enrico Mini, Stefania Nobi |
Sotorasib as Fourth-Line Treatment in Pancreatic Cancer: A Case Report and Literature Review. Rhode Island medical journal (2013) 2024 6 107 (7): 10-13. Ifeanyi David Onukogu, Georgio Medawar, Yashvin Onkarappa Mangala, Ritesh Ratho |
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE. Annals of hematology 2024 6 . Keshu Zhou, Tingyu Wang, Ling Pan, Wei Xu, Jie Jin, Wei Zhang, Yu Hu, Jianda Hu, Ru Feng, Ping Li, Zhougang Liu, Peng Liu, Hongmei Jing, Sujun Gao, Huilai Zhang, Kang Yu, Zhao Wang, Xiongpeng Zhu, Zimin Sun, Fei Li, Dongmei Yan, Jianyu Weng, Lina Fu, Liping Wang, Tommi Salmi, Kenneth Wu, Lugui Q |
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants. Annals of hematology 2024 5 . María Belén Fontecha, María Del Rosario Anadón, Verónica Mercado Guzmán, Carmen Stanganelli, Camila Galvano, Fernanda Tosin, Javier Bordone, Raimundo Bezares, Cecilia Rodríguez, Viviana Heller, Irma Slavutsky, Ariela Freya Fund |
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 2024 4 8 e2300647. Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwa |
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study. HemaSphere 2024 10 8 (10): e70017. Gian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, Simone Celant, Lydia Scarfò, Maria Pia Ballardini, Antonio Urso, Silvia Gambara, Francesco Cavazzini, Paolo Ghia, Antonio Cuneo, Pierluigi Rus |
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines 2024 10 12 (10): . Alessandra Virga, Caterina Gianni, Michela Palleschi, Davide Angeli, Filippo Merloni, Roberta Maltoni, Paola Ulivi, Giovanni Martinelli, Ugo De Giorgi, Sara Bravacci |
Circulating tumor DNA in conjunctival melanoma: landscape and surveillance value. American journal of ophthalmology 2024 10 . Hao Tian, Hanhan Shi, Jie Chen, Tianyu Zhu, Ziyue Huang, Chunyan Zong, Shichong Jia, Jing Ruan, Shengfang Ge, Haihua Yuan, Yanjie Zhang, Bin Jiang, Rong Liu, Renbing Jia, Xianqun Fan, Shiqiong |
Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN). Genes, chromosomes & cancer 2024 10 63 (10): e23270. Julia Doll, Katja Maurus, Franziska Köhler, Niels Matthes, Johan F Lock, Christoph-Thomas Germer, Andreas Rosenwald, Armin Wiegeri |
Genomic features of newly diagnosed large B cell lymphoma with or without subsequent disease progression. Cancer research communications 2024 10 . Daniel J Landsburg, Jennifer J D Morrissette, Sunita D Nasta, Stefan K Barta, Stephen J Schuster, Elise A Chong, Jakub Svoboda, Ashley Barlev, Adam Bagg, Salvatore F Prio |
Evaluation of the Prognostic Role of TP53 Gene Mutations in Prostate Cancer Outcome: A Systematic Review and Meta-Analysis. Clinical genitourinary cancer 2024 10 22 (6): 102226. Mohammad Moein Maddah, Akbar Hedayatizadeh-Omran, Mahmood Moosazadeh, Reza Alizadeh-Nava |
GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis. Therapeutic advances in medical oncology 2024 1 16 17588359231225038. Hong Yuan, Fei Xu, Shengzhou Wang, Di Liu, Huan Zhang, Jun Zhang, Min Shi, Chao Yan, Zhenggang Z |
Prognostic analysis of extrameningeal solitary fibrous tumor using the modified Demicco model: a clinicopathologic study of 111 Chinese cases. Frontiers in oncology 2024 1 13 1272090. Chen-Chen Yao, Jian Zhou, Xiao Li, Jun Yang, Gang Chen, Jia Wei, Qin-He Fan, Qi-Xing Go |
Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC). Translational lung cancer research 2024 1 12 (12): 2448-2459. Dae-Ho Choi, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon L |
Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases. Heliyon 2025 1 10 (24): e40703. Liqun Li, Zhe Huang, Yangqian Chen, Hongzhi Ma, Xiaoquan Chen, Huan Yan, Haoyue Qin, Yuda Zhang, Xing Zhang, Wenjuan Jiang, Zhan Wang, Lin Zhang, Fanxu Zeng, Zhiguo Zhou, Xingxiang Pu, Nong Yang, Liang Zeng, Yongchang Zha |
- Page last reviewed:Feb 1, 2024
- Content source: